Group One Trading
IMUX icon

Group One Trading’s Immunic IMUX Stock Holding History

Group One Trading’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-20
Closed -$107 – 8131
2025
Q4 		$107 Hold
20
– – ﹤0.01% 7915
2025
Q3 		$176 Sell
20
-220
-92% -$1.94K ﹤0.01% 8221
2025
Q2 		$1.67K Sell
240
-520
-68% -$4.77K ﹤0.01% 7457
2025
Q1 		$8.28K Sell
760
-7,220
-90% -$77.9K ﹤0.01% 6384
2024
Q4 		$79.8K Buy
7,980
+970
+14% +$12.2K ﹤0.01% 4698
2024
Q3 		$116K Buy
7,010
+90
+1% +$1.28K ﹤0.01% 4049
2024
Q2 		$76.8K Buy
6,920
+1,150
+20% +$14.3K ﹤0.01% 4165
2024
Q1 		$76.2K Buy
5,770
+1,180
+26% +$15.3K ﹤0.01% 4371
2023
Q4 		$68.8K Buy
4,590
+1,720
+60% +$21.1K ﹤0.01% 4800
2023
Q3 		$42.2K Buy
2,870
+1,400
+95% +$26.9K ﹤0.01% 5266
2023
Q2 		$36.9K Sell
1,470
-200
-12% -$3.35K ﹤0.01% 5513
2023
Q1 		$24.9K Sell
1,670
-1,060
-39% -$19.7K ﹤0.01% 5366
2022
Q4 		$38.2K Buy
2,730
+2,490
+1,038% +$67.9K ﹤0.01% 5196
2022
Q3 		$8K Sell
240
-70
-23% -$2.93K ﹤0.01% 6631
2022
Q2 		$11K Sell
310
-330
-52% -$21.1K ﹤0.01% 6708
2022
Q1 		$72K Sell
640
-150
-19% -$17.4K ﹤0.01% 5806
2021
Q4 		$76K Buy
790
+350
+80% +$31.5K ﹤0.01% 5971
2021
Q3 		$39K Sell
440
-10
-2% -$984 ﹤0.01% 6734
2021
Q2 		$55K Sell
450
-100
-18% -$13.8K ﹤0.01% 6488
2021
Q1 		$88K Buy
550
+390
+244% +$66.2K ﹤0.01% 5769
2020
Q4 		$24K Sell
160
-770
-83% -$138K ﹤0.01% 5417
2020
Q3 		$173K Buy
+930
New +$152K ﹤0.01% 3774
2019
Q3 		– Sell
-2,380
Closed -$273K – 5324
2019
Q2 		$273K Buy
+2,380
New +$313K ﹤0.01% 2621
2019
Q1 		– Sell
-30
Closed -$2K – 5059
2018
Q4 		$2K Sell
30
-114
-79% -$13.3K ﹤0.01% 4656
2018
Q3 		$16K Buy
144
+80
+125% +$209K ﹤0.01% 4467
2018
Q2 		$176K Buy
64
+61
+2,033% +$141K ﹤0.01% 3152
2018
Q1 		$7K Sell
3
-15
-83% -$34.4K ﹤0.01% 4416
2017
Q4 		$42K Buy
18
+1
+6% +$2.21K ﹤0.01% 3822
2017
Q3 		$35K Buy
+17
New +$22.2K ﹤0.01% 3804
2017
Q1 		– Sell
-10
Closed -$17K – 4793
2016
Q4 		$17K Hold
10
– – ﹤0.01% 3761
2016
Q3 		$23K Hold
10
– – ﹤0.01% 3729
2016
Q2 		$25K Sell
10
-51
-84% -$168K ﹤0.01% 3692
2016
Q1 		$221K Buy
61
+8
+15% +$27.8K ﹤0.01% 2255
2015
Q4 		$245K Sell
53
-8
-13% -$26.1K ﹤0.01% 2343
2015
Q3 		$99K Buy
61
+28
+85% +$140K ﹤0.01% 3048
2015
Q2 		$279K Buy
33
+18
+120% +$172K ﹤0.01% 2285
2015
Q1 		$150K Buy
+15
New +$138K ﹤0.01% 2597

Other funds holding IMUX

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Group One Trading's IMUX Position: Q1 2026 in Review

Group One Trading opened a new position in Immunic (IMUX) in Q1 2026: 170 shares worth $1.89K. The stake represents ﹤0.01% of the portfolio and ranks #7071 among its holdings. This is a return to the name: Group One Trading previously reported a position in IMUX as recently as Q2 2025.

Group One Trading first reported a position in IMUX in Q1 2015 and has held it in 27 quarters since. The position peaked at $203K in Q1 2022. 75 funds tracked by Wall St. Rank hold IMUX as of Q1 2026.

  • Group One Trading held 170 shares of Immunic worth $1.89K as of Q1 2026.
  • Immunic was a new Group One Trading position in Q1 2026.
  • Immunic made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7071 holding.
  • Group One Trading first reported a position in Immunic in Q1 2015 and has held it in 27 quarters since.
  • Group One Trading's Immunic position peaked at $203K in Q1 2022.
  • 75 funds tracked by Wall St. Rank held Immunic as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.